Advanced Devices For Injectable Drugs: Products, Players And Prospects - 2013 Report
DUBLIN, Ireland, March 25, 2013 /PRNewswire/ --
Research and Markets has announced the addition of the " Advanced Devices for Injectable Drugs. Products, Players and Prospects" report to their offering.
The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as specialty syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices and healthcare facilities to patient homes. This report examines injection devices engineered with features that advance the state-of-the-art for injectable drugs, providing essential insight and forecasts into the implications of this evolving landscape.Highlights - Analyzes and evaluates the shifting landscape for injectable drug delivery and assesses the market impact of new and emerging injection devices on the competitive landscape - Analyzes advanced syringe and injector device designs, feature/functionality, product branding, competing technologies and market development issues - Provides detailed descriptions advanced devices for injectable drugs and assesses the impact of advanced features on therapeutic segments - Profiles leading injection device companies, their product development activities, business strategies, and corporate alliances and affiliations Key Topics Covered: 1. Executive Summary 2. Injectable Drug Market Dynamics 3. The Injectable Drug Ecosystem - Therapeutic Demand Drivers - Specialty Injection Device Demand Drivers - Chronic Conditions and Self-Administration - The Growth of Biologicals - Shifting Patient Demographics - Drug Economics, Safety and Compliance - Device Design and Innovation - Competitive Landscape - Technology Market Drivers 4. Advanced Autoinjectors
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV